Understanding your gut with 'Try This'
In the first class in our course on the gut microbiome, host Cristina Quinn speaks with gastroenterologist Trisha Pasricha about the leading role the gut microbiome plays in our digestive health and how certain foods support its function.
Read more of Pasricha's work, including eight tips to improve gut health and why probiotics can be a waste of money. For more advice, follow her on Instagram.
To hear more, check out 'Try This' wherever you listen to podcasts.
Now 'Try This' has a newsletter! Think of it as a supplemental guide and sign up here.
Subscribe to The Washington Post or connect your subscription in Apple Podcasts.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
UnitedHealth Group (UNH) Responds to the Department of Justice
UnitedHealth Group Incorporated (NYSE:UNH) is one of the top low volatility healthcare stocks to buy now. On July 24, UnitedHealth Group Incorporated (NYSE:UNH) released a statement responding to the Department of Justice after a review of the media reports about investigations into specific aspects of its involvement in the Medicare program. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH) stated that it has now begun complying with the formal criminal and civil requests from the Department, and has 'full confidence in its practices and is committed to working cooperatively with the Department throughout this process'. It added that UnitedHealth Group Incorporated (NYSE:UNH) has a historical record of 'responsible conduct and effective compliance,' with independent CMS audits showing that its practices are ranked 'among the most accurate in the industry.' Management stated that after a decade-long civil challenge by the Department to aspects of the company's Medicare Advantage business, 'a court-appointed Special Master concluded there was no evidence to support claims of wrongdoing'. UnitedHealth Group Incorporated (NYSE:UNH) has launched its own initiative to provide confidence and transparency to stakeholders, focusing on conducting 'third-party reviews of policies, practices, and associated processes and performance metrics for risk assessment coding, managed care practices, and pharmacy services.' UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments, which have solid operations. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Medscape
23 minutes ago
- Medscape
Cancer Care Costs High Among Privately Insured Patients
TOPLINE: A recent analysis found that privately insured US patients with newly diagnosed cancer, especially those with more advanced disease, had 'substantial out-of-pocket costs.' Monthly out-of-pocket costs among these patients increased by a mean of almost $600, on average, but increased to nearly $720 per month for those with stage IV disease. METHODOLOGY: Out-of-pocket costs for cancer care in the US are rising, but most research has focused on Medicare beneficiaries. It's important to understand privately insured patients' financial burdens, especially with cancer rates growing among younger Americans. Researchers conducted a retrospective study of 19,656 patients with cancer, using a dataset that links claims from a large private insurer to the Surveillance, Epidemiology, and End Results cancer registry. Overall, 74.1% had breast cancer, 14.5% had colorectal cancer, and 11.4% had lung cancer. Analyses also included 26,502 individuals without cancer who were assigned pseudo – diagnosis date. Monthly out-of-pocket costs (copays, co-insurance, and deductibles) were calculated from claims and inflation-adjusted to 2024 US dollars. TAKEAWAY: After a cancer diagnosis, monthly out-of-pocket costs rose by $592, on average. Those added costs increased with disease stage, from $462 per month for stage 0 cancer to $720 per month for stage IV cancer. Out-of-pocket costs spiked in the month of diagnosis and remained elevated for 6 months compared with those in individuals without cancer — totaling an average of $4145 in cumulative additional costs (over 7 months). IN PRACTICE: 'In this cohort study, patients with private insurance were found to have high OOPCs [out-of-pocket costs] after an incident diagnosis of cancer, and those with the most advanced cancer had the highest OOPCs,' the authors wrote. 'The variability in OOPCs based on cancer stage underscores the need for policies such as paid sick leave, that address both insurance continuity and financial assistance, especially for patients with more advanced cancer.' SOURCE: This study, led by Liam Rose, PhD, Stanford University School of Medicine, Palo Alto, California, was published online in JAMA Network Open. LIMITATIONS: Differential insurance attrition could have affected the results: Patients with stage IV cancer were most likely to drop their coverage. The study could only capture direct medical costs, which misses other potential financial burdens, such as lost income and travel expenses. DISCLOSURES: This study received funding support through a grant from the American Cancer Society. One author reported receiving grants from the Department of Veterans Affairs and National Institutes of Health during the conduct of the study. No other disclosures were reported. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
26 minutes ago
- Yahoo
Family of boy who died from brain-eating amoeba speaks out: 'Unimaginable'
The family of a 12-year-old boy from South Carolina is grieving after he died from a brain-eating amoeba, according to a statement from their lawyer. Jaysen Carr died on July 18 after developing an infection from the brain-eating amoeba Naegleria fowleri, the statement shared by Bailey Law Firm said. The South Carolina Department of Public Health confirmed in a statement to USA TODAY on July 23 that a person died after being exposed to the amoeba earlier in July. Prisma Health Children's Hospital Midlands confirmed on July 22 that the person was treated at the facility but did not publicly identify the person. "The Carr family is incredibly grateful for the outpouring of love from the community and for the dedicated care provided by the doctors and nurses at Prisma Health Children's Hospital in the Midlands," the statement said. Brain-eating amoeba victim was 'bright and beloved' middle schooler The statement from the Carr family's lawyer said Jaysen was a "bright and beloved" middle school student. "His loss is unimaginable, and our hearts are with his family as they grieve their son and search for answers," the statement said. The legal team said it will "stand beside this family not only to seek the truth, but to help ensure no other family endures a loss like this." "We ask that you keep the Carrs in your thoughts and prayers and respect their privacy as they prepare to lay Jaysen to rest," Bailey Law Firm's statement said. Brain-eating amoeba: Person dies from Naegleria fowleri in South Carolina, officials say Family says boy was infected with brain-eating amoeba at SC lake The family's statement also said Jaysen Carr developed the infection after swimming at Lake Murray outside Columbia. The SCDPH said it also believed the exposure occurred at the lake. "We cannot be completely certain as this organism occurs naturally and is present in many warm water lakes, rivers and streams," the agency said. What is Naegleria fowleri? Why is it known as a brain-eating amoeba? Naegleria fowleri is a type of amoeba that can cause a rare but nearly always fatal brain infection. It thrives in warm freshwater lakes, rivers and hot springs, according to the Centers for Disease Control and Prevention. The amoeba is often referred to as brain-eating because it can cause an infection called primary amebic meningoencephalitis (PAM) that destroys brain tissue. Most people who have been in bodies of waters have been exposed to the amoeba, but contact alone is not harmful, Dr. Anna Kathryn Burch, a pediatric infectious disease specialist at Prisma Health Children's Hospital Midlands, said during a news conference on July 22. "Where it can cause an issue is if forceful water gets up the nose and is able to cross from the nose into the brain," Burch said, adding that a PAM infection causes the brain to swell. To protect against a possible infection, the CDC recommends holding or wearing a nose clip when jumping into fresh water, keeping the head above water in hot springs and using distilled or boiled tap water when rinsing sinuses. Melina Khan is a national trending reporter for USA TODAY. She can be reached at This article originally appeared on USA TODAY: 12-year-old dies from brain-eating amoeba after swimming in lake
